Profile: Enzon, Inc. is a bio-pharmaceutical company. We develop therapeutics to treat patients with cancer and other life-threatening diseases. Our specialized products include Abelcet®, Oncaspar®, Adagen®, & Depocyt®. We provide single chain antigen binding technologies to modify pharmacokinetics of drugs. Our strategy includes an extensive drug development program, that leverages our proprietary technologies, which includes a next-generation PEGylation platform that utilizes linkers designed to release compounds.